Andrew Cooper
Stock Analyst at Raymond James
(2.43)
# 2,398
Out of 4,876 analysts
140
Total ratings
45.16%
Success rate
-1.15%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Reiterates: Strong Buy | $115 → $105 | $75.03 | +39.94% | 9 | May 9, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $5.22 | +91.75% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $20.00 | +25.00% | 2 | May 5, 2025 | |
| HOLX Hologic | Reiterates: Outperform | $90 → $71 | $65.26 | +8.80% | 12 | May 2, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $145 → $120 | $98.19 | +22.21% | 8 | Apr 29, 2025 | |
| ITGR Integer Holdings | Maintains: Outperform | $145 → $150 | $122.99 | +21.96% | 2 | Apr 25, 2025 | |
| UFPT UFP Technologies | Initiates: Market Perform | n/a | $243.15 | - | 1 | Mar 28, 2025 | |
| GH Guardant Health | Reiterates: Outperform | $39 → $59 | $51.50 | +14.56% | 3 | Feb 21, 2025 | |
| AVTR Avantor | Reiterates: Outperform | $26 → $24 | $13.71 | +75.12% | 14 | Feb 10, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $650 → $667 | $412.33 | +61.77% | 6 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $200.61 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $53.85 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.41 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $168.41 | -49.53% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $28.75 | +164.35% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.63 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $30.02 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.34 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.98 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.03 | - | 5 | Sep 22, 2021 |
Haemonetics
May 9, 2025
Reiterates: Strong Buy
Price Target: $115 → $105
Current: $75.03
Upside: +39.94%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $5.22
Upside: +91.75%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $20.00
Upside: +25.00%
Hologic
May 2, 2025
Reiterates: Outperform
Price Target: $90 → $71
Current: $65.26
Upside: +8.80%
Revvity
Apr 29, 2025
Reiterates: Outperform
Price Target: $145 → $120
Current: $98.19
Upside: +22.21%
Integer Holdings
Apr 25, 2025
Maintains: Outperform
Price Target: $145 → $150
Current: $122.99
Upside: +21.96%
UFP Technologies
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $243.15
Upside: -
Guardant Health
Feb 21, 2025
Reiterates: Outperform
Price Target: $39 → $59
Current: $51.50
Upside: +14.56%
Avantor
Feb 10, 2025
Reiterates: Outperform
Price Target: $26 → $24
Current: $13.71
Upside: +75.12%
Thermo Fisher Scientific
Feb 3, 2025
Reiterates: Outperform
Price Target: $650 → $667
Current: $412.33
Upside: +61.77%
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $200.61
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $53.85
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $19.41
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $168.41
Upside: -49.53%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $28.75
Upside: +164.35%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $3.63
Upside: -
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $30.02
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.34
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $26.98
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.03
Upside: -